Trial Profile
A Study to Evaluate the Clinical Risk Factors for Severe Tenofovir Disoproxil Fumarate (TDF) Associated Renal Tubulopathy in Patients With HIV Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 25 Apr 2016 New trial record